Phase I/II pharmacokinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancer.

Paridaens, Robert; Dirix, Luc; Dumez, Herlinde; Prové, Annemie; Wildiers, Hans; Alvarez, Ana; Oliveira, Celia Tosello; Latz, Jane; Simms, Lorinda; Melemed, Allen

Paridaens, Robert; Dirix, Luc; Dumez, Herlinde; Prové, Annemie; Wildiers, Hans; Alvarez, Ana; Oliveira, Celia Tosello; Latz, Jane; Simms, Lorinda; Melemed, Allen.

Affiliation

Paridaens R; Universitair Ziekenhuis Gasthuisberg, Katholieke Universiteit Leuven, Belgium. robert.paridaens@uz.kuleuven.ac.be

Clin Breast Cancer ; 7(11): 861-6, 2007 Dec.

Article in En | MEDLINE | ID: mdl-18269776

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics; Breast Neoplasms/drug therapy; Adult; Aged; Antimetabolites, Antineoplastic/administration & dosage; Bone Neoplasms/secondary; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin/administration & dosage; Female; Glutamates/administration & dosage; Guanine/administration & dosage; Guanine/analogs & derivatives; Humans; Liver Neoplasms/secondary; Lung Neoplasms/secondary; Middle Aged; Neoplasm Metastasis; Pemetrexed; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Clin Breast Cancer Journal subject: NEOPLASIAS Year: 2007 Document type: Article Affiliation country: Belgium Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google